Gene Summary
IMPC Data Collections
- Body Weight Measurements
- No Embryo Imaging Data
- Viability Data
The IMPC applies a panel of phenotyping screens to characterise single-gene knockout mice by comparison to wild types. Click on the different tabs to visualise significant phenotypes identified by the IMPC, as well as all data that was measured.
An assay measuring the expression of lacZ shows the tissue where the gene is expressed.
Anatomy | Images | Zygosity | Mutant Expr |
---|---|---|---|
Bone | Wholemount images | hemizygote | Ambiguous |
Bone | Wholemount images | heterozygote | Ambiguous |
Bone | Wholemount images | homozygote | Ambiguous |
Brain | Wholemount images | hemizygote | 100% (2 of 2) |
Brain | Wholemount images | heterozygote | 100% (2 of 2) |
Brain | Wholemount images | homozygote | 100% (1 of 1) |
Cecum | Wholemount images | hemizygote | Ambiguous |
Cecum | Wholemount images | heterozygote | Ambiguous |
Cecum | Wholemount images | homozygote | Ambiguous |
Chest bone | Wholemount images | hemizygote | Ambiguous |
Chest bone | Wholemount images | heterozygote | Ambiguous |
Chest bone | Wholemount images | homozygote | Ambiguous |
Duodenum | Wholemount images | hemizygote | Ambiguous |
Duodenum | Wholemount images | heterozygote | Ambiguous |
Duodenum | Wholemount images | homozygote | Ambiguous |
Epididymis | Wholemount images | hemizygote | Ambiguous |
Gall bladder | Wholemount images | hemizygote | Ambiguous |
Gall bladder | Wholemount images | heterozygote | Ambiguous |
Gall bladder | Wholemount images | homozygote | Ambiguous |
Harderian gland | Wholemount images | hemizygote | Ambiguous |
Harderian gland | Wholemount images | heterozygote | Ambiguous |
Harderian gland | Wholemount images | homozygote | Ambiguous |
Ileum | Wholemount images | hemizygote | Ambiguous |
Ileum | Wholemount images | heterozygote | Ambiguous |
Ileum | Wholemount images | homozygote | Ambiguous |
Jejunum | Wholemount images | hemizygote | Ambiguous |
Jejunum | Wholemount images | heterozygote | Ambiguous |
Jejunum | Wholemount images | homozygote | Ambiguous |
Kidney | Wholemount images | hemizygote | Ambiguous |
Kidney | Wholemount images | heterozygote | Ambiguous |
Kidney | Wholemount images | homozygote | Ambiguous |
Large intestine | Wholemount images | hemizygote | Ambiguous |
Large intestine | Wholemount images | heterozygote | Ambiguous |
Large intestine | Wholemount images | homozygote | Ambiguous |
Liver | Wholemount images | hemizygote | 0.0% (0 of 2) |
Liver | Wholemount images | heterozygote | 0.0% (0 of 2) |
Liver | Wholemount images | homozygote | Ambiguous |
Lung | Wholemount images | hemizygote | Ambiguous |
Lung | Wholemount images | heterozygote | Ambiguous |
Lung | Wholemount images | homozygote | Ambiguous |
Lymph node | Wholemount images | heterozygote | 0.0% (0 of 2) |
Lymph node | Wholemount images | homozygote | Ambiguous |
Mesenteric lymph node | Wholemount images | hemizygote | Ambiguous |
Mesenteric lymph node | Wholemount images | heterozygote | Ambiguous |
Mesenteric lymph node | Wholemount images | homozygote | Ambiguous |
Ovary | Wholemount images | heterozygote | Ambiguous |
Ovary | Wholemount images | homozygote | Ambiguous |
Oviduct | Wholemount images | heterozygote | Ambiguous |
Oviduct | Wholemount images | homozygote | Ambiguous |
Parotid gland | Wholemount images | hemizygote | 0.0% (0 of 2) |
Parotid gland | Wholemount images | heterozygote | Ambiguous |
Parotid gland | Wholemount images | homozygote | Ambiguous |
Pituitary gland | Wholemount images | homozygote | Ambiguous |
Prostate gland | Wholemount images | hemizygote | Ambiguous |
Skin | Wholemount images | hemizygote | Ambiguous |
Skin | Wholemount images | heterozygote | 0.0% (0 of 2) |
Spinal cord | Wholemount images | hemizygote | Ambiguous |
Spinal cord | Wholemount images | heterozygote | 0.0% (0 of 2) |
Spinal cord | Wholemount images | homozygote | 100% (1 of 1) |
Spleen | Wholemount images | hemizygote | Ambiguous |
Spleen | Wholemount images | heterozygote | Ambiguous |
Spleen | Wholemount images | homozygote | Ambiguous |
Stomach | Wholemount images | hemizygote | Ambiguous |
Stomach | Wholemount images | heterozygote | Ambiguous |
Stomach | Wholemount images | homozygote | Ambiguous |
Sublingual gland | Wholemount images | hemizygote | 0.0% (0 of 2) |
Sublingual gland | Wholemount images | heterozygote | Ambiguous |
Sublingual gland | Wholemount images | homozygote | Ambiguous |
Submandibular gland | Wholemount images | hemizygote | Ambiguous |
Submandibular gland | Wholemount images | heterozygote | 0.0% (0 of 2) |
Submandibular gland | Wholemount images | homozygote | Ambiguous |
Testis | Wholemount images | hemizygote | Ambiguous |
Thyroid gland | Wholemount images | hemizygote | Ambiguous |
Thyroid gland | Wholemount images | heterozygote | Ambiguous |
Thyroid gland | Wholemount images | homozygote | Ambiguous |
Trigeminal V nerve | Wholemount images | homozygote | 0.0% (0 of 1) |
Urinary bladder | Wholemount images | hemizygote | Ambiguous |
Urinary bladder | Wholemount images | heterozygote | Ambiguous |
Urinary bladder | Wholemount images | homozygote | Ambiguous |
Uterus | Wholemount images | heterozygote | Ambiguous |
Uterus | Wholemount images | homozygote | Ambiguous |
Vesicular gland | Wholemount images | hemizygote | Ambiguous |
Adrenal gland | N/A | hemizygote | 0.0% (0 of 2) |
Adrenal gland | N/A | heterozygote | 0.0% (0 of 2) |
Adrenal gland | N/A | homozygote | 0.0% (0 of 1) |
Aorta | N/A | hemizygote | 0.0% (0 of 2) |
Aorta | N/A | heterozygote | 0.0% (0 of 2) |
Aorta | N/A | homozygote | 0.0% (0 of 1) |
Brainstem | N/A | hemizygote | 0.0% (0 of 2) |
Brainstem | N/A | heterozygote | 0.0% (0 of 2) |
Brainstem | N/A | homozygote | 0.0% (0 of 1) |
Brown adipose tissue | N/A | hemizygote | 0.0% (0 of 2) |
Brown adipose tissue | N/A | heterozygote | 0.0% (0 of 2) |
Brown adipose tissue | N/A | homozygote | 0.0% (0 of 1) |
Cartilage tissue | N/A | hemizygote | Ambiguous |
Cartilage tissue | N/A | heterozygote | Ambiguous |
Cartilage tissue | N/A | homozygote | Ambiguous |
Cerebellum | N/A | hemizygote | 0.0% (0 of 2) |
Cerebellum | N/A | heterozygote | 0.0% (0 of 2) |
Cerebellum | N/A | homozygote | 0.0% (0 of 1) |
Cerebral cortex | N/A | hemizygote | 100% (2 of 2) |
Cerebral cortex | N/A | heterozygote | 100% (2 of 2) |
Cerebral cortex | N/A | homozygote | 100% (1 of 1) |
Colon | N/A | hemizygote | Ambiguous |
Colon | N/A | heterozygote | Ambiguous |
Colon | N/A | homozygote | Ambiguous |
Cranium | N/A | hemizygote | Ambiguous |
Cranium | N/A | heterozygote | Ambiguous |
Cranium | N/A | homozygote | Ambiguous |
Diaphragm | N/A | hemizygote | 0.0% (0 of 2) |
Diaphragm | N/A | heterozygote | 0.0% (0 of 2) |
Diaphragm | N/A | homozygote | 0.0% (0 of 1) |
Epididymis | N/A | heterozygote | Not available |
Epididymis | N/A | homozygote | Not available |
Esophagus | N/A | hemizygote | 0.0% (0 of 2) |
Esophagus | N/A | heterozygote | 0.0% (0 of 2) |
Esophagus | N/A | homozygote | 0.0% (0 of 1) |
Eye | N/A | hemizygote | 0.0% (0 of 2) |
Eye | N/A | heterozygote | 0.0% (0 of 2) |
Eye | N/A | homozygote | 0.0% (0 of 1) |
Gonadal fat pad | N/A | hemizygote | 0.0% (0 of 2) |
Gonadal fat pad | N/A | heterozygote | 0.0% (0 of 2) |
Gonadal fat pad | N/A | homozygote | 0.0% (0 of 1) |
Heart | N/A | hemizygote | 0.0% (0 of 2) |
Heart | N/A | heterozygote | 0.0% (0 of 2) |
Heart | N/A | homozygote | 0.0% (0 of 1) |
Hindlimb | N/A | hemizygote | 0.0% (0 of 2) |
Hindlimb | N/A | heterozygote | 0.0% (0 of 2) |
Hindlimb | N/A | homozygote | 0.0% (0 of 1) |
Hippocampus | N/A | hemizygote | 0.0% (0 of 2) |
Hippocampus | N/A | heterozygote | 0.0% (0 of 2) |
Hippocampus | N/A | homozygote | 0.0% (0 of 1) |
Hypothalamus | N/A | hemizygote | 0.0% (0 of 2) |
Hypothalamus | N/A | heterozygote | 0.0% (0 of 2) |
Hypothalamus | N/A | homozygote | 0.0% (0 of 1) |
Lower urinary tract | N/A | hemizygote | Ambiguous |
Lower urinary tract | N/A | heterozygote | Ambiguous |
Lower urinary tract | N/A | homozygote | Ambiguous |
Lymph node | N/A | hemizygote | 0.0% (0 of 2) |
Main olfactory bulb | N/A | hemizygote | 0.0% (0 of 2) |
Main olfactory bulb | N/A | heterozygote | 0.0% (0 of 2) |
Main olfactory bulb | N/A | homozygote | 0.0% (0 of 1) |
Mammary gland | N/A | hemizygote | Not available |
Mammary gland | N/A | heterozygote | 0.0% (0 of 2) |
Mammary gland | N/A | homozygote | 0.0% (0 of 1) |
Mesenteric adipose tissue | N/A | hemizygote | 0.0% (0 of 2) |
Mesenteric adipose tissue | N/A | heterozygote | 0.0% (0 of 2) |
Mesenteric adipose tissue | N/A | homozygote | 0.0% (0 of 1) |
Midbrain | N/A | hemizygote | 0.0% (0 of 2) |
Midbrain | N/A | heterozygote | 0.0% (0 of 2) |
Midbrain | N/A | homozygote | 0.0% (0 of 1) |
Olfactory lobe | N/A | hemizygote | 0.0% (0 of 2) |
Olfactory lobe | N/A | heterozygote | 0.0% (0 of 2) |
Olfactory lobe | N/A | homozygote | 0.0% (0 of 1) |
Oral epithelium | N/A | hemizygote | 0.0% (0 of 2) |
Oral epithelium | N/A | heterozygote | 0.0% (0 of 2) |
Oral epithelium | N/A | homozygote | 0.0% (0 of 1) |
Ovary | N/A | hemizygote | Not available |
Oviduct | N/A | hemizygote | Not available |
Pancreas | N/A | hemizygote | 0.0% (0 of 2) |
Pancreas | N/A | heterozygote | 0.0% (0 of 2) |
Pancreas | N/A | homozygote | 0.0% (0 of 1) |
Parathyroid gland | N/A | hemizygote | 0.0% (0 of 2) |
Parathyroid gland | N/A | heterozygote | 0.0% (0 of 2) |
Parathyroid gland | N/A | homozygote | 0.0% (0 of 1) |
Penis | N/A | hemizygote | 0.0% (0 of 2) |
Penis | N/A | heterozygote | Not available |
Penis | N/A | homozygote | Not available |
Peripheral nervous system | N/A | hemizygote | 0.0% (0 of 2) |
Peripheral nervous system | N/A | heterozygote | 0.0% (0 of 2) |
Peripheral nervous system | N/A | homozygote | 0.0% (0 of 1) |
Peyer's patch | N/A | hemizygote | 0.0% (0 of 2) |
Peyer's patch | N/A | heterozygote | 0.0% (0 of 2) |
Peyer's patch | N/A | homozygote | 0.0% (0 of 1) |
Pituitary gland | N/A | hemizygote | 0.0% (0 of 2) |
Pituitary gland | N/A | heterozygote | 0.0% (0 of 2) |
Prostate gland | N/A | heterozygote | Not available |
Prostate gland | N/A | homozygote | Not available |
Quadriceps | N/A | hemizygote | 0.0% (0 of 2) |
Quadriceps | N/A | heterozygote | 0.0% (0 of 2) |
Quadriceps | N/A | homozygote | 0.0% (0 of 1) |
Sciatic nerve | N/A | hemizygote | 0.0% (0 of 2) |
Sciatic nerve | N/A | heterozygote | 0.0% (0 of 2) |
Sciatic nerve | N/A | homozygote | 0.0% (0 of 1) |
Skeletal muscle | N/A | hemizygote | 0.0% (0 of 2) |
Skeletal muscle | N/A | heterozygote | 0.0% (0 of 2) |
Skeletal muscle | N/A | homozygote | 0.0% (0 of 1) |
Skin | N/A | homozygote | 0.0% (0 of 1) |
Small intestine | N/A | hemizygote | Ambiguous |
Small intestine | N/A | heterozygote | Ambiguous |
Small intestine | N/A | homozygote | Ambiguous |
Stomach pyloric region | N/A | hemizygote | 0.0% (0 of 2) |
Stomach pyloric region | N/A | heterozygote | 0.0% (0 of 2) |
Stomach pyloric region | N/A | homozygote | 0.0% (0 of 1) |
Striatum | N/A | hemizygote | 0.0% (0 of 2) |
Striatum | N/A | heterozygote | 0.0% (0 of 2) |
Striatum | N/A | homozygote | 100% (1 of 1) |
Testis | N/A | heterozygote | Not available |
Testis | N/A | homozygote | Not available |
Thalamus | N/A | hemizygote | 0.0% (0 of 2) |
Thalamus | N/A | heterozygote | 0.0% (0 of 2) |
Thalamus | N/A | homozygote | 0.0% (0 of 1) |
Thymus | N/A | hemizygote | 0.0% (0 of 2) |
Thymus | N/A | heterozygote | 0.0% (0 of 2) |
Thymus | N/A | homozygote | 0.0% (0 of 1) |
Tongue | N/A | hemizygote | 0.0% (0 of 2) |
Tongue | N/A | heterozygote | 0.0% (0 of 2) |
Tongue | N/A | homozygote | 0.0% (0 of 1) |
Trachea | N/A | hemizygote | 0.0% (0 of 2) |
Trachea | N/A | heterozygote | 0.0% (0 of 2) |
Trachea | N/A | homozygote | 0.0% (0 of 1) |
Trigeminal V nerve | N/A | hemizygote | 0.0% (0 of 2) |
Trigeminal V nerve | N/A | heterozygote | 0.0% (0 of 2) |
Uterus | N/A | hemizygote | Not available |
Vagina | N/A | hemizygote | Not available |
Vagina | N/A | heterozygote | 0.0% (0 of 2) |
Vagina | N/A | homozygote | 0.0% (0 of 1) |
Vas deferens | N/A | hemizygote | Ambiguous |
Vas deferens | N/A | heterozygote | Not available |
Vas deferens | N/A | homozygote | Not available |
Vascular system | N/A | hemizygote | 0.0% (0 of 2) |
Vascular system | N/A | heterozygote | 0.0% (0 of 2) |
Vascular system | N/A | homozygote | 0.0% (0 of 1) |
Vesicular gland | N/A | heterozygote | Not available |
Vesicular gland | N/A | homozygote | Not available |
White adipose tissue | N/A | hemizygote | 0.0% (0 of 2) |
White adipose tissue | N/A | heterozygote | 0.0% (0 of 2) |
White adipose tissue | N/A | homozygote | 0.0% (0 of 1) |
An assay measuring the expression of lacZ shows the tissue where the gene is expressed.
Anatomy | Images | Zygosity | Mutant Expr |
---|---|---|---|
Embryo | N/A | heterozygote | 0.0% (0 of 5) |
Head | N/A | heterozygote | 0.0% (0 of 5) |
Brain | N/A | heterozygote | 0.0% (0 of 5) |
Ear | N/A | heterozygote | 0.0% (0 of 5) |
Eye | N/A | heterozygote | 0.0% (0 of 5) |
Footplate | N/A | heterozygote | 0.0% (0 of 5) |
Forearm | N/A | heterozygote | 0.0% (0 of 5) |
Forebrain | N/A | heterozygote | 0.0% (0 of 5) |
Forelimb | N/A | heterozygote | 0.0% (0 of 5) |
Handplate | N/A | heterozygote | 0.0% (0 of 5) |
Heart | N/A | heterozygote | 0.0% (0 of 5) |
Hindbrain | N/A | heterozygote | 0.0% (0 of 5) |
Hindlimb | N/A | heterozygote | 0.0% (0 of 5) |
Liver | N/A | heterozygote | 0.0% (0 of 5) |
Lower leg | N/A | heterozygote | 0.0% (0 of 5) |
Lung | N/A | heterozygote | 0.0% (0 of 5) |
Mandibular process | N/A | heterozygote | 0.0% (0 of 5) |
Maxillary process | N/A | heterozygote | 0.0% (0 of 5) |
Midbrain | N/A | heterozygote | 0.0% (0 of 5) |
Oral cavity | N/A | heterozygote | 0.0% (0 of 5) |
Skin | N/A | heterozygote | 0.0% (0 of 5) |
Tail somite | N/A | heterozygote | 0.0% (0 of 5) |
Tail | N/A | heterozygote | 0.0% (0 of 5) |
Upper arm | N/A | heterozygote | 0.0% (0 of 5) |
Upper leg | N/A | heterozygote | 0.0% (0 of 5) |
Background staining occurs in wild type mice and embryos at an incidental rate.
Anatomy | Background staining in controls (WT) |
---|---|
adrenal gland | 0.0% |
aorta | 0.0% |
bone | 0.0% |
brain | 0.0% |
brainstem | 0.0% |
brown adipose tissue | 0.0% |
cartilage tissue | 0.0% |
cecum | 0.0% |
cerebellum | 0.0% |
cerebral cortex | 0.0% |
chest bone | |
colon | |
cranium | |
diaphragm | 0.0% |
duodenum | 0.0% |
epididymis | Unavailable |
esophagus | 0.0% |
eye | 0.0% |
gall bladder | 0.0% |
gonadal fat pad | 0.0% |
harderian gland | |
heart | 0.0% |
hindlimb | 0.0% |
hippocampus | 0.0% |
hypothalamus | 0.0% |
ileum | 0.0% |
jejunum | |
kidney | 0.0% |
large intestine | 0.0% |
liver | 0.0% |
lower urinary tract | 0.0% |
lung | 0.0% |
lymph node | 0.0% |
main olfactory bulb | 0.0% |
mammary gland | 0.0% |
mesenteric adipose tissue | 0.0% |
mesenteric lymph node | |
midbrain | 0.0% |
olfactory lobe | 0.0% |
oral epithelium | 0.0% |
ovary | 0.0% |
oviduct | 0.0% |
pancreas | 0.0% |
parathyroid gland | 0.0% |
parotid gland | 0.0% |
penis | 0.0% |
peripheral nervous system | 0.0% |
peyers patch | 0.0% |
pituitary gland | 0.0% |
prostate gland | 0.0% |
quadriceps | 0.0% |
sciatic nerve | 0.0% |
skeletal muscle | 0.0% |
skin | 0.0% |
small intestine | 0.0% |
spinal cord | 0.0% |
spleen | 0.0% |
stomach | 0.0% |
stomach pyloric region | 0.0% |
striatum | 0.0% |
sublingual gland | 0.0% |
submandibular gland | 0.0% |
testis | 0.0% |
thalamus | 0.0% |
thymus | 0.0% |
thyroid gland | 0.0% |
tongue | 0.0% |
trachea | 0.0% |
trigeminal v nerve | 0.0% |
urinary bladder | |
uterus | 0.0% |
vagina | 0.0% |
vas deferens | Unavailable |
vascular system | 0.0% |
vesicular gland | Unavailable |
white adipose tissue | 0.0% |
Background staining occurs in wild type mice and embryos at an incidental rate.
Background staining occurs in wild type embryos at a measurable rate.
Anatomy | Background staining in controls(WT) |
---|---|
brain | 0.0% |
ear | 0.0% |
embryo | 0.0% |
eye | 0.0% |
footplate | 0.0% |
forearm | Ambiguous |
forebrain | 0.0% |
forelimb | 0.0% |
handplate | 0.0% |
head | 0.0% |
heart | 0.0% |
hindbrain | 0.0% |
hindlimb | 0.0% |
liver | 0.0% |
lower leg | Ambiguous |
lung | 0.0% |
mandibular process | 0.0% |
maxillary process | 0.0% |
midbrain | 0.0% |
oral cavity | 0.0% |
skin | 0.0% |
tail | 0.0% |
tail somite group | 0.0% |
upper arm | Ambiguous |
upper leg | Ambiguous |
The analysis uses data from IMPC, along with published data on other mouse mutants, in comparison to human disease reports in OMIM, Orphanet, and DECIPHER.
Phenotype comparisons summarize the similarity of mouse phenotypes with human disease phenotypes.
The table below shows human diseases predicted to be associated to Apln by phenotypic similarity.
Disease | Similarity of phenotypes |
Matching phenotypes | Source |
---|---|---|---|
Microphthalmia-Ankyloblepharon-Intellectual Disability Syndrome | Microphthalmia, Anophthalmia | ORPHA:85275 | |
Microphthalmia, Isolated 1 | Microphthalmia, Anophthalmia | OMIM:251600 | |
Microphthalmia, Isolated, With Coloboma 10 | Microphthalmia, Anophthalmia | OMIM:616428 | |
Microphthalmia, Isolated, With Coloboma 5 | Microphthalmia, Anophthalmia, Bilateral microphthalmos | OMIM:611638 | |
Familial Atrial Fibrillation | Exercise intolerance, Fatigue, Atrial fibrillation, Myocardial infarction, Syncope, Chest pain, P... | ORPHA:334 | |
Microphthalmia, Syndromic 16 | Microphthalmia, Anophthalmia | OMIM:611038 | |
Pulmonary Blastoma | Weight loss | ORPHA:64741 | |
Tuberculosis | Weight loss | ORPHA:3389 | |
Fryns Microphthalmia Syndrome | Microphthalmia, Anophthalmia | OMIM:600776 | |
Microphthalmia, Isolated 8 | Microphthalmia, Anophthalmia, Optic nerve hypoplasia, True anophthalmia | OMIM:615113 | |
Microphthalmia, Syndromic 12 | Microphthalmia, Anophthalmia | OMIM:615524 | |
Idiopathic/Heritable Pulmonary Arterial Hypertension | Fatigue, Tricuspid regurgitation, Abnormal cardiovascular system physiology, Heart murmur, Syncop... | ORPHA:422 | |
Mantle Cell Lymphoma | Weight loss | ORPHA:52416 | |
Anencephaly 2 | Anophthalmia | OMIM:619452 | |
Atrial Standstill | Fatigue, Ventricular escape rhythm, Cardiac conduction abnormality, Atrial standstill, Congestive... | ORPHA:1344 | |
Oculocerebrocutaneous Syndrome | Microphthalmia, Anophthalmia | OMIM:164180 | |
Idiopathic Achalasia | Weight loss | ORPHA:930 | |
Progressive Nodular Histiocytosis | Cachexia | ORPHA:158022 | |
Pulmonary Hypertension, Primary, 5 | Fatigue, Angina pectoris, Right ventricular failure, Syncope, Pulmonary arterial hypertension | OMIM:265400 | |
Atrial Septal Defect, Sinus Venosus Type | Fatigue, Automatic atrial tachycardia, Atrial flutter, Tricuspid regurgitation, Left-to-right shu... | ORPHA:99105 | |
Meckel Syndrome, Type 8 | Microphthalmia, Anophthalmia | OMIM:613885 | |
Isolated Congenital Hypoglossia/Aglossia | Weight loss | ORPHA:141152 | |
Undifferentiated Pleomorphic Sarcoma | Weight loss | ORPHA:2023 | |
Autosomal Dominant Congenital Benign Spinal Muscular Atrophy | Cachexia | ORPHA:1216 | |
Liddle Syndrome | Fatigue, Hypertension, Arrhythmia, Cerebral ischemia | ORPHA:526 | |
Early-Onset Epileptic Encephalopathy-Cortical Blindness-Intellectual Disability-Facial Dysmorphism Syndrome | Anophthalmia | ORPHA:411986 | |
Chronic Hiccup | Weight loss | ORPHA:396 | |
Intestinal Dysmotility Syndrome | Failure to thrive, Weight loss | OMIM:620045 | |
Huntington Disease-Like 2 | Weight loss | ORPHA:98934 | |
Isaacs Syndrome | Weight loss | ORPHA:84142 | |
Congenital Heart Block | Fatigue, Exercise intolerance, Cyanosis, First degree atrioventricular block, Gallop rhythm, Cong... | ORPHA:60041 | |
Arthrogryposis-Like Hand Anomaly-Sensorineural Deafness Syndrome | Cachexia | ORPHA:1144 | |
Isolated Right Ventricular Hypoplasia | Fatigue, Tricuspid regurgitation, Cyanosis, Abnormal atrioventricular conduction, Right ventricul... | ORPHA:439 | |
Acquired Methemoglobinemia | Fatigue, Tachycardia, Cyanosis, Abdominal pain, Hypoxemia, Syncope, Palpitations, Arrhythmia | ORPHA:464453 | |
Mulibrey Nanism | Cachexia | ORPHA:2576 | |
Multicentric Reticulohistiocytosis | Cachexia | ORPHA:139436 | |
Matthew-Wood Syndrome | Anophthalmia, Microphthalmia, Failure to thrive | ORPHA:2470 | |
Trisomy 13 | Aplasia/Hypoplasia of the iris, Microphthalmia, Anophthalmia | ORPHA:3378 | |
Mitochondrial Dna Depletion Syndrome 8A (Encephalomyopathic Type With Renal Tubulopathy) | Failure to thrive, Cachexia, Weight loss | OMIM:612075 | |
Galactose Epimerase Deficiency | Weight loss | ORPHA:79238 | |
Laryngeal Neuroendocrine Tumor | Weight loss | ORPHA:100083 | |
Anophthalmia Plus Syndrome | Anophthalmia | ORPHA:1104 | |
Mitochondrial Dna Depletion Syndrome 4B (Mngie Type) | Slender build, Cachexia, Weight loss | OMIM:613662 | |
Microphthalmia With Limb Anomalies | Anophthalmia, Microphthalmia, Failure to thrive | OMIM:206920 | |
Insulin Autoimmune Syndrome | Weight loss | ORPHA:411593 | |
Diencephalic Syndrome | Cachexia, Decreased body weight | ORPHA:1672 | |
Loeffler Endocarditis | Aortic regurgitation, Fatigue, Pericarditis, Left ventricular diastolic dysfunction, Congestive h... | ORPHA:75566 | |
Oculotrichoanal Syndrome | Microphthalmia, Anophthalmia | ORPHA:2717 | |
Hydrolethalus | Microphthalmia, Anophthalmia | ORPHA:2189 | |
Cerebrooculonasal Syndrome | Anophthalmia | ORPHA:66625 | |
Microphthalmia, Syndromic 5 | Microphthalmia, Anophthalmia, Optic nerve hypoplasia | OMIM:610125 | |
Acute Myelomonocytic Leukemia | Weight loss | ORPHA:517 | |
Microphthalmia With Brain And Digit Anomalies | Microphthalmia, Anophthalmia | ORPHA:139471 | |
Solitary Median Maxillary Central Incisor | Microphthalmia, Anophthalmia | OMIM:147250 | |
Moynahan Syndrome | Cachexia | ORPHA:2574 | |
Nodular Lymphocyte Predominant Hodgkin Lymphoma | Weight loss | ORPHA:86893 | |
Anophthalmia/Microphthalmia-Esophageal Atresia Syndrome | Microphthalmia, Anophthalmia | ORPHA:77298 | |
Atrial Septal Defect, Ostium Secundum Type | Bundle branch block, First degree atrioventricular block, Abnormal left ventricular function, Sup... | ORPHA:99103 | |
Atrial Septal Defect, Coronary Sinus Type | Fatigue, Bundle branch block, Exercise intolerance, Left-to-right shunt, Abnormally loud pulmonic... | ORPHA:99104 | |
Palmoplantar Keratoderma-Esophageal Carcinoma Syndrome | Weight loss | ORPHA:2198 | |
Inflammatory Bowel Disease 11 | Weight loss | OMIM:191390 | |
Huntington Disease-Like 2 | Weight loss | OMIM:606438 | |
Atrial Septal Defect, Ostium Primum Type | First degree atrioventricular block, Atrioventricular block, Fixed splitting of the second heart ... | ORPHA:99106 | |
Hereditary Central Diabetes Insipidus | Weight loss | ORPHA:30925 | |
Focal Myositis | Weight loss | ORPHA:48918 | |
Cockayne Syndrome Type 2 | Anophthalmia | ORPHA:90322 | |
Corticosteroid-Binding Globulin Deficiency | Fatigue, Hypertension, Asthenia, Hypotension | OMIM:611489 | |
Manitoba Oculotrichoanal Syndrome | Microphthalmia, Anophthalmia | OMIM:248450 | |
Walker-Warburg Syndrome | Microphthalmia, Anophthalmia | ORPHA:899 | |
Trisomy 1Q | Anophthalmia | ORPHA:261344 | |
Reticular Dysgenesis | Failure to thrive, Weight loss | ORPHA:33355 | |
Central Diabetes Insipidus | Failure to thrive, Weight loss | ORPHA:178029 | |
Nephroblastoma | Aniridia, Weight loss | ORPHA:654 | |
Ebstein Malformation Of The Tricuspid Valve | Fatigue, Atrial fibrillation, Sudden cardiac death, Congestive heart failure, Right bundle branch... | ORPHA:1880 | |
Mu-Heavy Chain Disease | Weight loss | ORPHA:100024 | |
Mast Cell Sarcoma | Weight loss | ORPHA:66661 | |
Attrv30M Amyloidosis | Weight loss | ORPHA:85447 | |
Follicular Lymphoma | Weight loss | ORPHA:545 | |
Hypercalcemia, Infantile, 1 | Failure to thrive, Weight loss | OMIM:143880 | |
Acquired Central Diabetes Insipidus | Weight loss | ORPHA:95626 | |
Cockayne Syndrome Type 1 | Anophthalmia, Failure to thrive | ORPHA:90321 | |
Erythrokeratodermia Variabilis | Weight loss | ORPHA:317 | |
Perry Syndrome | Weight loss | ORPHA:178509 | |
Hirschsprung Disease | Failure to thrive in infancy, Weight loss | ORPHA:388 | |
Juvenile Huntington Disease | Weight loss | ORPHA:248111 | |
Alexander Disease Type I | Failure to thrive, Cachexia | ORPHA:363717 | |
Oculopharyngodistal Myopathy | Weight loss | ORPHA:98897 | |
Pleural Mesothelioma | Weight loss | ORPHA:50251 | |
Inflammatory Bowel Disease (Crohn Disease) 1 | Weight loss | OMIM:266600 | |
Allergic Bronchopulmonary Aspergillosis | Weight loss | ORPHA:1164 | |
Takayasu Arteritis | Arterial stenosis, Weight loss | ORPHA:3287 | |
Ring Chromosome 10 Syndrome | Microphthalmia, Cachexia | ORPHA:1438 | |
Congenital Muscular Dystrophy Due To Lmna Mutation | Cachexia | ORPHA:157973 | |
Pfapa Syndrome | Weight loss | ORPHA:42642 | |
Pseudomyxoma Peritonei | Weight loss | ORPHA:26790 | |
Spinocerebellar Ataxia 48 | Cachexia | OMIM:618093 | |
Autosomal Dominant Epidermolytic Ichthyosis | Weight loss | ORPHA:312 | |
Microphthalmia/Coloboma And Skeletal Dysplasia Syndrome | Microphthalmia, Anophthalmia | OMIM:615877 | |
Liposarcoma | Weight loss | ORPHA:69078 | |
Cap Polyposis | Weight loss | ORPHA:160148 | |
Microphthalmia, Syndromic 9 | Anophthalmia, Bilateral microphthalmos | OMIM:601186 | |
Bullous Pemphigoid | Weight loss | ORPHA:703 | |
Microphthalmia, Syndromic 3 | Microphthalmia, Optic nerve aplasia, Anophthalmia, Optic nerve hypoplasia | OMIM:206900 | |
Parkinson Disease 4, Autosomal Dominant | Weight loss | OMIM:605543 | |
Holoprosencephaly | Microphthalmia, Anophthalmia, Failure to thrive in infancy | ORPHA:2162 | |
Cortical Blindness-Intellectual Disability-Polydactyly Syndrome | Cachexia | ORPHA:1389 | |
Peritoneal Cystic Mesothelioma | Weight loss | ORPHA:168816 | |
Mcdonough Syndrome | Cachexia | ORPHA:2471 | |
Vacterl With Hydrocephalus | Microphthalmia, Anophthalmia | ORPHA:3412 | |
Osteosarcoma | Weight loss | ORPHA:668 | |
Bone Dysplasia, Lethal Holmgren Type | Failure to thrive, Weight loss | ORPHA:1842 | |
Graves Disease, Susceptibility To, 1 | Weight loss | OMIM:275000 | |
Microgastria-Limb Reduction Defect Syndrome | Anophthalmia, Microphthalmia, Failure to thrive | ORPHA:2538 | |
Malignant Peritoneal Mesothelioma | Weight loss | ORPHA:168811 | |
Congenital Enterocyte Heparan Sulfate Deficiency | Weight loss | ORPHA:103910 | |
Fibular Hemimelia | Anophthalmia | ORPHA:93323 | |
Thyrotoxic Periodic Paralysis, Susceptibility To, 1 | Weight loss | OMIM:188580 | |
Anophthalmia-Megalocornea-Cardiopathy-Skeletal Anomalies Syndrome | Aniridia, Anophthalmia | ORPHA:1101 | |
Thymic Carcinoma | Weight loss | ORPHA:99868 | |
Huntington Disease | Decreased body mass index, Weight loss | ORPHA:399 | |
Hyposmia-Nasal And Ocular Hypoplasia-Hypogonadotropic Hypogonadism Syndrome | Microphthalmia, Anophthalmia | ORPHA:2250 | |
Rhabdoid Tumor | Weight loss | ORPHA:69077 | |
Pemphigus Vulgaris | Weight loss | ORPHA:704 | |
Mitochondrial Neurogastrointestinal Encephalomyopathy | Cachexia, Weight loss | ORPHA:298 | |
Christianson Syndrome | Cachexia | ORPHA:85278 | |
Acquired Hypertrichosis Lanuginosa | Weight loss | ORPHA:2221 | |
Lipodystrophy Due To Peptidic Growth Factors Deficiency | Cachexia, Weight loss | ORPHA:1979 | |
Huntington Disease-Like 1 | Weight loss | ORPHA:157941 | |
Desmoplastic Small Round Cell Tumor | Cachexia, Weight loss | ORPHA:83469 | |
Thyrotoxic Periodic Paralysis, Susceptibility To, 2 | Weight loss | OMIM:613239 | |
Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2 | Failure to thrive in infancy, Cachexia | OMIM:616801 | |
Cerebrooculonasal Syndrome | Anophthalmia, Optic nerve hypoplasia | OMIM:605627 | |
Immunodeficiency 27A | Weight loss | OMIM:209950 | |
Isolated Succinate-Coq Reductase Deficiency | Weight loss | ORPHA:3208 | |
Riboflavin Transporter Deficiency | Cachexia | ORPHA:97229 | |
Tropical Endomyocardial Fibrosis | Prolonged QRS complex, Restrictive cardiomyopathy, Atrioventricular block, Left bundle branch blo... | ORPHA:75565 | |
Benign Recurrent Intrahepatic Cholestasis | Weight loss | ORPHA:65682 | |
Classic Hodgkin Lymphoma | Weight loss | ORPHA:391 | |
Eosinophilic Fasciitis | Weight loss | ORPHA:3165 | |
Chronic Beryllium Disease | Weight loss | ORPHA:133 | |
14Q22Q23 Microdeletion Syndrome | Optic nerve aplasia, Anophthalmia | ORPHA:264200 | |
Renpenning Syndrome | Cachexia | ORPHA:3242 | |
Non-Functioning Paraganglioma | Weight loss | ORPHA:94080 | |
Idiopathic Bronchiectasis | Cachexia | ORPHA:60033 | |
Microcephaly-Lymphedema-Chorioretinopathy Syndrome | Microphthalmia, Anophthalmia | ORPHA:2526 | |
X-Linked Agammaglobulinemia | Failure to thrive, Weight loss | ORPHA:47 | |
Kaposi Sarcoma | Weight loss | ORPHA:33276 | |
Wilson Disease | Failure to thrive, Increased body weight, Weight loss | ORPHA:905 | |
Holoprosencephaly 9 | Microphthalmia, Anophthalmia, Optic nerve hypoplasia | OMIM:610829 | |
Microphthalmia With Linear Skin Defects Syndrome | Anophthalmia, Microphthalmia, Failure to thrive | ORPHA:2556 | |
Leishmaniasis | Weight loss | ORPHA:507 | |
Glucose-Galactose Malabsorption | Failure to thrive, Weight loss | ORPHA:35710 | |
Polyarteritis Nodosa | Weight loss | ORPHA:767 | |
Majeed Syndrome | Failure to thrive, Cachexia, Weight loss | ORPHA:77297 | |
Pulmonary Non-Tuberculous Mycobacterial Infection | Weight loss | ORPHA:411703 | |
Meckel Syndrome | Aplasia/Hypoplasia of the iris, Microphthalmia, Anophthalmia | ORPHA:564 | |
Flynn-Aird Syndrome | Cachexia | ORPHA:2047 | |
Mitochondrial Dna Depletion Syndrome, Encephalomyopathic Form With Methylmalonic Aciduria | Cachexia | ORPHA:1933 | |
Generalized Pseudohypoaldosteronism Type 1 | Failure to thrive in infancy, Weight loss | ORPHA:171876 | |
Classic Pantothenate Kinase-Associated Neurodegeneration | Weight loss | ORPHA:216866 | |
Deafness-Lymphedema-Leukemia Syndrome | Weight loss | ORPHA:3226 | |
Familial Thrombocytosis | Peripheral arterial stenosis, Weight loss | ORPHA:71493 | |
Holocarboxylase Synthetase Deficiency | Weight loss | ORPHA:79242 | |
Anaplastic Thyroid Carcinoma | Weight loss | ORPHA:142 | |
Yao Syndrome | Weight loss | OMIM:617321 | |
Respiratory Bronchiolitis-Interstitial Lung Disease Syndrome | Weight loss | ORPHA:79127 | |
Short Syndrome | Hypoplasia of the iris, Weight loss | ORPHA:3163 | |
Tetrasomy 12P | Cachexia | ORPHA:884 | |
Joubert Syndrome 21 | Anophthalmia | OMIM:615636 | |
Laryngotracheoesophageal Cleft Type 4 | Cachexia | ORPHA:93941 | |
8P23.1 Microdeletion Syndrome | Pulmonary artery stenosis, Obesity, Weight loss | ORPHA:251071 | |
Subcutaneous Panniculitis-Like T-Cell Lymphoma | Weight loss | ORPHA:86884 | |
Multicentric Carpo-Tarsal Osteolysis With Or Without Nephropathy | Cachexia | ORPHA:2774 | |
Rheumatoid Arthritis | Weight loss | OMIM:180300 | |
Cryptogenic Organizing Pneumonia | Weight loss | ORPHA:1302 | |
Medullary Thyroid Carcinoma | Weight loss | ORPHA:1332 | |
Microphthalmia, Syndromic 2 | Microphthalmia, Anophthalmia, Decreased body weight | OMIM:300166 | |
Hypotonia-Speech Impairment-Severe Cognitive Delay Syndrome | Severe failure to thrive, Cachexia | ORPHA:371364 | |
Microphthalmia With Limb Anomalies | Microphthalmia, Failure to thrive, True anophthalmia | ORPHA:1106 | |
Perry Syndrome | Weight loss | OMIM:168605 | |
Secondary Short Bowel Syndrome | Failure to thrive, Weight loss | ORPHA:95427 | |
Medium Chain Acyl-Coa Dehydrogenase Deficiency | Cachexia | ORPHA:42 | |
Oromandibular Dystonia | Weight loss | ORPHA:93958 | |
Fatal Familial Insomnia | Weight loss | OMIM:600072 | |
Cronkhite-Canada Syndrome | Cachexia | ORPHA:2930 | |
Eosinophilic Gastroenteritis | Weight loss | ORPHA:2070 | |
Pelizaeus-Merzbacher Disease | Failure to thrive in infancy, Cachexia | ORPHA:702 | |
Idiopathic Chronic Eosinophilic Pneumonia | Weight loss | ORPHA:2902 | |
Neuropathy, Congenital Hypomyelinating, 3 | Cachexia | OMIM:618186 | |
Proboscis Lateralis | Microphthalmia, Anophthalmia, Optic nerve hypoplasia | ORPHA:141099 | |
Wolman Disease | Cachexia | ORPHA:75233 | |
Inflammatory Pseudotumor Of The Liver | Weight loss | ORPHA:90003 | |
Wild Type Attr Amyloidosis | Weight loss | ORPHA:330001 | |
Congenital Tufting Enteropathy | Failure to thrive, Weight loss | ORPHA:92050 | |
Neuroblastoma, Susceptibility To, 1 | Failure to thrive, Weight loss | OMIM:256700 | |
Charge Syndrome | Microphthalmia, Anophthalmia | ORPHA:138 | |
Fraser Syndrome 1 | Anophthalmia, Bilateral microphthalmos | OMIM:219000 | |
Igg4-Related Aortitis | Weight loss | ORPHA:449400 | |
Klatskin Tumor | Weight loss | ORPHA:99978 | |
Gm1 Gangliosidosis | Failure to thrive, Weight loss | ORPHA:354 | |
Ménétrier Disease | Weight loss | ORPHA:2494 | |
Diffuse Alveolar Hemorrhage | Weight loss | ORPHA:90060 | |
Acute Monoblastic/Monocytic Leukemia | Weight loss | ORPHA:514 | |
Aggressive Systemic Mastocytosis | Weight loss | ORPHA:98850 | |
Focal Dermal Hypoplasia | Aniridia, Microphthalmia, Anophthalmia | OMIM:305600 | |
Aredyld Syndrome | Cachexia | ORPHA:1133 | |
Nodular Non-Suppurative Panniculitis | Weight loss | ORPHA:33577 | |
Chronic Nonbacterial Osteomyelitis/Chronic Recurrent Multifocal Osteomyelitis | Weight loss | ORPHA:324964 | |
Familial Hyperthyroidism Due To Mutations In Tsh Receptor | Small for gestational age, Weight loss | ORPHA:424 | |
Oculogastrointestinal Muscular Dystrophy | Cachexia | ORPHA:1876 | |
Pneumocystosis | Weight loss | ORPHA:723 | |
Corticosteroid-Sensitive Aseptic Abscess Syndrome | Weight loss | ORPHA:54251 | |
Systemic Capillary Leak Syndrome | Weight loss | ORPHA:188 | |
Carney-Stratakis Syndrome | Weight loss | ORPHA:97286 | |
Felty Syndrome | Weight loss | ORPHA:47612 | |
19Q13.11 Microdeletion Syndrome | Failure to thrive, Cachexia | ORPHA:217346 | |
Thymic Neuroendocrine Tumor | Weight loss | ORPHA:97289 | |
Polymyositis | Weight loss | ORPHA:732 | |
Refractory Celiac Disease | Weight loss | ORPHA:398063 | |
Imerslund-Gräsbeck Syndrome | Failure to thrive, Weight loss | ORPHA:35858 | |
Fraser Syndrome | Microphthalmia, Anophthalmia | ORPHA:2052 | |
Microphthalmia, Syndromic 6 | Anophthalmia, Microphthalmia, Failure to thrive | OMIM:607932 | |
Renal Nutcracker Syndrome | Renal artery stenosis, Weight loss | ORPHA:71273 | |
Aicardi-Goutieres Syndrome 9 | Failure to thrive, Weight loss | OMIM:619487 | |
Celiac Disease, Susceptibility To, 1 | Failure to thrive, Weight loss | OMIM:212750 | |
Adrenocortical Carcinoma | Increased body weight, Weight loss | ORPHA:1501 | |
Silver-Russell Syndrome | Failure to thrive in infancy, Obesity, Cachexia | ORPHA:813 | |
Lymphoid Interstitial Pneumonia | Failure to thrive, Weight loss | ORPHA:79128 | |
Symptomatic Form Of Hfe-Related Hemochromatosis | Weight loss | ORPHA:465508 | |
X-Linked Creatine Transporter Deficiency | Cachexia | ORPHA:52503 | |
Budd-Chiari Syndrome | Weight loss | ORPHA:131 | |
Acrodermatitis Enteropathica | Failure to thrive, Weight loss | ORPHA:37 | |
Solitary Fibrous Tumor | Weight loss | ORPHA:2126 | |
Acute Promyelocytic Leukemia | Weight loss | ORPHA:520 | |
Hereditary Pheochromocytoma-Paraganglioma | Aniridia, Weight loss | ORPHA:29072 | |
Neuroendocrine Tumor Of The Colon | Weight loss | ORPHA:100080 | |
Familial Glucocorticoid Deficiency | Failure to thrive, Weight loss | ORPHA:361 | |
Osteootohepatoenteric Syndrome | Failure to thrive, Weight loss | OMIM:619377 | |
Primary Myelofibrosis | Cachexia | ORPHA:824 | |
Fryns-Smeets-Thiry Syndrome | Cachexia | ORPHA:2058 | |
Sporadic Pheochromocytoma/Secreting Paraganglioma | Weight loss | ORPHA:276621 | |
Gerstmann-Straussler Disease | Weight loss | OMIM:137440 | |
Charge Syndrome | Microphthalmia, Anophthalmia, Unilateral microphthalmos | OMIM:214800 | |
Lysosomal Acid Lipase Deficiency | Failure to thrive, Coronary artery atherosclerosis, Cachexia, Weight loss | ORPHA:275761 | |
Mitochondrial Dna Depletion Syndrome 1 (Mngie Type) | Slender build, Cachexia, Weight loss | OMIM:603041 | |
Drug Reaction With Eosinophilia And Systemic Symptoms | Weight loss | ORPHA:139402 | |
Infantile Krabbe Disease | Failure to thrive, Cachexia | ORPHA:206436 | |
Eosinophilic Granulomatosis With Polyangiitis | Weight loss | ORPHA:183 | |
Glossopharyngeal Neuralgia | Weight loss | ORPHA:221098 | |
Primary Intestinal Lymphangiectasia | Weight loss | ORPHA:90362 | |
Rett Syndrome | Cachexia | OMIM:312750 | |
Polyposis, Skin Pigmentation, Alopecia, And Fingernail Changes | Cachexia | OMIM:175500 | |
Beta-Ketothiolase Deficiency | Weight loss | ORPHA:134 | |
Giant Cell Arteritis | Weight loss | ORPHA:397 | |
Bronchial Neuroendocrine Tumor | Weight loss | ORPHA:97287 | |
Juvenile Amyotrophic Lateral Sclerosis | Cachexia | ORPHA:300605 | |
Peripheral Primitive Neuroectodermal Tumor | Weight loss | ORPHA:370348 | |
Neuroendocrine Tumor Of The Rectum | Weight loss | ORPHA:100081 | |
Neuroendocrine Tumor Of Anal Canal | Weight loss | ORPHA:100082 | |
Late-Onset Isolated Acth Deficiency | Failure to thrive, Weight loss | ORPHA:199299 | |
Thymoma | Weight loss | ORPHA:99867 | |
Familial Gestational Hyperthyroidism | Weight loss | ORPHA:99819 | |
X-Linked Intellectual Disability, Cabezas Type | Obesity, Cachexia | ORPHA:85293 | |
Hereditary Amyloidosis With Primary Renal Involvement | Weight loss | ORPHA:85450 | |
Cystic Echinococcosis | Weight loss | ORPHA:400 | |
Autoimmune Pulmonary Alveolar Proteinosis | Weight loss | ORPHA:747 | |
Pancreatoblastoma | Weight loss | ORPHA:677 | |
Primary Hepatic Neuroendocrine Carcinoma | Weight loss | ORPHA:100085 | |
Branchiooculofacial Syndrome | Microphthalmia, Anophthalmia | OMIM:113620 | |
Poems Syndrome | Weight loss | ORPHA:2905 | |
Amoebiasis Due To Entamoeba Histolytica | Weight loss | ORPHA:67 | |
Deafness-Small Bowel Diverticulosis-Neuropathy Syndrome | Cachexia | ORPHA:3217 | |
3-Hydroxy-3-Methylglutaric Aciduria | Weight loss | ORPHA:20 | |
Polycythemia Vera | Weight loss | ORPHA:729 | |
Insulin-Resistance Syndrome Type B | Abnormality of body weight, Decreased body weight, Increased body weight, Weight loss | ORPHA:2298 | |
X-Linked Alport Syndrome-Diffuse Leiomyomatosis | Failure to thrive, Weight loss | ORPHA:1018 | |
Al Amyloidosis | Weight loss | ORPHA:85443 | |
Lynch Syndrome | Weight loss | ORPHA:144 | |
Whipple Disease | Cachexia | ORPHA:3452 | |
Malignant Atrophic Papulosis | Weight loss | ORPHA:679 | |
Xfe Progeroid Syndrome | Failure to thrive, Cachexia | OMIM:610965 | |
Pyomyositis | Weight loss | ORPHA:764 | |
Familial Colorectal Cancer Type X | Weight loss | ORPHA:440437 | |
Simple Cryoglobulinemia | Weight loss | ORPHA:91139 | |
Systemic Mastocytosis With Associated Hematologic Neoplasm | Weight loss | ORPHA:98849 | |
Tropical Pancreatitis | Weight loss | ORPHA:103918 | |
Hereditary Late-Onset Parkinson Disease | Weight loss | ORPHA:411602 | |
Sensory Ataxic Neuropathy, Dysarthria, And Ophthalmoparesis | Weight loss | OMIM:607459 | |
Trisomy 18 | Microphthalmia, Cachexia | ORPHA:3380 | |
Gallbladder Neuroendocrine Tumor | Weight loss | ORPHA:100086 | |
Anemia, Congenital Dyserythropoietic, Type Iv | Weight loss | OMIM:613673 | |
Acute Adrenal Insufficiency | Failure to thrive, Weight loss | ORPHA:95409 | |
Granulomatosis With Polyangiitis | Weight loss | OMIM:608710 | |
Juvenile Dermatomyositis | Weight loss | ORPHA:93672 | |
Neuroendocrine Tumor Of Stomach | Weight loss | ORPHA:100075 | |
Schwartz-Jampel Syndrome | Aplasia/Hypoplasia affecting the eye, Cachexia, Decreased body weight | ORPHA:800 | |
Caroli Disease | Weight loss | ORPHA:53035 | |
Q Fever | Weight loss | ORPHA:781 | |
Igg4-Related Retroperitoneal Fibrosis | Weight loss | ORPHA:49041 | |
Fanconi Anemia | Aplasia/Hypoplasia of the iris, Microphthalmia, Weight loss | ORPHA:84 | |
Castleman Disease | Weight loss | ORPHA:160 | |
Thyrotoxic Periodic Paralysis | Obesity, Weight loss | ORPHA:79102 | |
Alveolar Echinococcosis | Weight loss | ORPHA:284 | |
Isolated Permanent Neonatal Diabetes Mellitus | Failure to thrive, Weight loss | ORPHA:99885 | |
Hermansky-Pudlak Syndrome | Weight loss | ORPHA:79430 | |
Stevens-Johnson Syndrome | Weight loss | ORPHA:36426 | |
Familial Pancreatic Carcinoma | Weight loss | ORPHA:1333 | |
Toxic Epidermal Necrolysis | Weight loss | ORPHA:537 | |
Pancreatic Triacylglycerol Lipase Deficiency | Weight loss | ORPHA:309031 | |
Malt Lymphoma | Weight loss | ORPHA:52417 | |
Immune Dysregulation-Polyendocrinopathy-Enteropathy-X-Linked Syndrome | Failure to thrive in infancy, Cachexia | ORPHA:37042 | |
Riddle Syndrome | Weight loss | ORPHA:420741 | |
Erdheim-Chester Disease | Weight loss | ORPHA:35687 | |
Xeroderma Pigmentosum-Cockayne Syndrome Complex | Cachexia | ORPHA:220295 | |
Bannayan-Riley-Ruvalcaba Syndrome | Cachexia | ORPHA:109 | |
Seckel Syndrome | Cachexia | ORPHA:808 | |
Mucolipidosis Type Ii | Weight loss | ORPHA:576 | |
Microsporidiosis | Cachexia, Weight loss | ORPHA:2552 | |
Multiple Myeloma | Weight loss | ORPHA:29073 | |
Immunodeficiency 31C | Weight loss | OMIM:614162 | |
Congenital Fiber-Type Disproportion Myopathy | Failure to thrive, Weight loss | ORPHA:2020 | |
Addison Disease | Failure to thrive, Weight loss | ORPHA:85138 | |
Marfan Syndrome | Hypoplasia of the iris, Slender build, Increased axial length of the globe, Cachexia | ORPHA:558 | |
Rat-Bite Fever | Weight loss | ORPHA:31205 | |
Oculopharyngodistal Myopathy 1 | Weight loss | OMIM:164310 | |
Reactive Arthritis | Weight loss | ORPHA:29207 | |
Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis | Weight loss | ORPHA:85408 | |
Ileal Neuroendocrine Tumor | Weight loss | ORPHA:100078 | |
Facial Dysmorphism-Anorexia-Cachexia-Eye And Skin Anomalies Syndrome | Cachexia | ORPHA:1969 | |
Aicardi-Goutieres Syndrome 7 | Weight loss | OMIM:615846 | |
Craniofacial Microsomia 1 | Microphthalmia, Anophthalmia | OMIM:164210 | |
Microphthalmia, Syndromic 1 | Microphthalmia, Anophthalmia | OMIM:309800 | |
Primary Sclerosing Cholangitis | Weight loss | ORPHA:171 | |
Brucellosis | Failure to thrive, Small for gestational age, Weight loss | ORPHA:1304 | |
Ppoma | Weight loss | ORPHA:97278 | |
Tsh-Secreting Pituitary Adenoma | Weight loss | ORPHA:91347 | |
Cystinosis, Nephropathic | Failure to thrive in infancy, Weight loss | OMIM:219800 | |
Somatostatinoma | Weight loss | ORPHA:97283 | |
Granulomatosis With Polyangiitis | Weight loss | ORPHA:900 | |
Parathyroid Carcinoma | Weight loss | ORPHA:143 | |
Autoinflammatory Syndrome, Familial, X-Linked, Behcet-Like 2 | Weight loss | OMIM:301074 | |
Zollinger-Ellison Syndrome | Weight loss | ORPHA:913 | |
Grfoma | Weight loss | ORPHA:97261 | |
Vipoma | Weight loss | ORPHA:97282 | |
Cockayne Syndrome | Microphthalmia, Cachexia | ORPHA:191 | |
Glucagonoma | Weight loss | ORPHA:97280 | |
Pulmonary Alveolar Microlithiasis | Weight loss | ORPHA:60025 | |
Postinfectious Vasculitis | Weight loss | ORPHA:48435 | |
Behçet Disease | Weight loss | ORPHA:117 | |
Dermatomyositis | Weight loss | ORPHA:221 | |
Juvenile Polyposis Of Infancy | Cachexia | ORPHA:79076 | |
Nijmegen Breakage Syndrome | Cachexia | ORPHA:647 | |
Norrie Disease | Aplasia/Hypoplasia of the lens, Cachexia, Hypoplasia of the iris, Microphthalmia, Failure to thrive | ORPHA:649 | |
Primary Fanconi Renotubular Syndrome | Weight loss | ORPHA:3337 | |
Nocardiosis | Weight loss | ORPHA:31204 | |
Igg4-Related Dacryoadenitis And Sialadenitis | Weight loss | ORPHA:79078 | |
Multiple Endocrine Neoplasia Type 1 | Weight loss | ORPHA:652 | |
Hutchinson-Gilford Progeria Syndrome | Severe failure to thrive, Weight loss | ORPHA:740 | |
Classic Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency | Failure to thrive, Weight loss | ORPHA:90794 | |
Sarcoidosis, Susceptibility To, 1 | Weight loss | OMIM:181000 | |
Camurati-Engelmann Disease | Slender build, Cachexia | ORPHA:1328 | |
Kikuchi-Fujimoto Disease | Weight loss | ORPHA:50918 | |
Igg4-Related Kidney Disease | Weight loss | ORPHA:449395 | |
Choreoacanthocytosis | Weight loss | ORPHA:2388 | |
Immunodeficiency 82 With Systemic Inflammation | Weight loss | OMIM:619381 | |
Gaucher Disease-Ophthalmoplegia-Cardiovascular Calcification Syndrome | Cachexia | ORPHA:2072 | |
Stickler Syndrome | Slender build, Cachexia | ORPHA:828 | |
Cushing Syndrome Due To Ectopic Acth Secretion | Truncal obesity, Abdominal obesity, Increased body weight, Weight loss | ORPHA:99889 | |
Sarcoidosis | Weight loss | ORPHA:797 | |
Chronic Graft Versus Host Disease | Weight loss | ORPHA:99921 | |
Tubulointerstitial Nephritis And Uveitis Syndrome | Weight loss | ORPHA:91500 | |
Proteus Syndrome | Buphthalmos, Cachexia | ORPHA:744 | |
African Trypanosomiasis | Weight loss | ORPHA:3385 | |
Goodpasture Syndrome | Weight loss | OMIM:233450 |
The table below lists publications which used either products generated by the IMPC or data produced by the phenotyping efforts of the IMPC. These publications have also been associated to Apln.
There are 1 publication which use IMPC produced mice or data.
Title | Journal | IMPC Allele | PubMed ID |
---|---|---|---|
Aplnr knockout mice display sex-specific changes in conditioned fear. | Behavioural brain research (December 2020) | Aplnrtm1.1(KOMP)Vlcg | 33309737 |
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
MGI Allele | Allele Type | Produced |
---|---|---|
Aplntm1a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | Mice, Targeting vectors, ES Cells |
Aplntm1b(KOMP)Wtsi | Reporter-tagged deletion allele (with selection cassette) | Mice |
Aplntm3a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | Targeting vectors, ES Cells |
Aplntm1e(KOMP)Wtsi | Targeted, non-conditional allele | ES Cells |
Aplntm1(KOMP)Vlcg | Reporter-tagged deletion allele (with selection cassette) | ES Cells |
Get highlights of the most important data releases, news and events, delivered straight to your email inbox
Subscribe to newsletter